Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 218,261,783 papers from all fields of science
Search
Sign In
Create Free Account
Nemaline Myopathy, Autosomal Dominant
Known as:
Autosomal Dominant Nemaline Myopathy
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
2 relations
Adult Onset Nemaline Myopathy
Broader (1)
Myopathies, Nemaline
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2007
2007
A second pedigree with autosomal dominant nemaline myopathy caused by TPM3 mutation: A clinical and pathological study
I. Pénisson‐Besnier
,
N. Monnier
,
A. Toutain
,
F. Dubas
,
N. Laing
Neuromuscular Disorders
2007
Corpus ID: 19484218
2007
2007
Autosomal dominant nemaline myopathy: A new phenotype unlinked to previously known genetic loci
P. Jeannet
,
L. Mittaz
,
M. Dunand
,
J. Lobrinus
,
L. Bonafė
,
T. Kuntzer
Neuromuscular Disorders
2007
Corpus ID: 34235590
2002
2002
A new phenotype of autosomal dominant nemaline myopathy
I. Gommans
,
B. Engelen
,
+4 authors
O. Vogels
Neuromuscular Disorders
2002
Corpus ID: 22362343
2002
2002
Expression and biological activity of Baculovirus generated wild-type human slow alpha tropomyosin and the Met9Arg mutant responsible for a dominant form of nemaline myopathy.
P. Akkari
,
Yuhua Song
,
S. Hitchcock-DeGregori
,
L. Blechynden
,
N. Laing
Biochemical and Biophysical Research…
2002
Corpus ID: 24434288
Highly Cited
1992
Highly Cited
1992
Assignment of a gene (NEMI) for autosomal dominant nemaline myopathy to chromosome I.
N. Laing
,
B. Majda
,
+14 authors
B. Kakulas
American Journal of Human Genetics
1992
Corpus ID: 26422181
Nemaline myopathy (NEM) is a neuromuscular disorder characterized by the presence, in skeletal muscle, of nemaline rods composed…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE